USRE41045E1 - Method and apparatus for altering neural tissue function - Google Patents

Method and apparatus for altering neural tissue function Download PDF

Info

Publication number
USRE41045E1
USRE41045E1 US10460506 US46050603A USRE41045E1 US RE41045 E1 USRE41045 E1 US RE41045E1 US 10460506 US10460506 US 10460506 US 46050603 A US46050603 A US 46050603A US RE41045 E1 USRE41045 E1 US RE41045E1
Authority
US
Grant status
Grant
Patent type
Prior art keywords
tissue
frequency
function
high
signal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US10460506
Inventor
Menno E. Sluijter
William J. Rittman, III
Eric R. Cosman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Covidien AG
Original Assignee
Covidien AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36021External stimulators, e.g. with patch electrodes for treatment of pain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36017External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/40Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A61N1/403Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/08Arrangements or circuits for monitoring, protecting, controlling or indicating

Abstract

A method and apparatus for altering a function of neural tissue in a patient. An electromagnetic signal is applied to the neural tissue through an electrode. The electromagnetic signal has a frequency component above the physiological stimulation frequency range and an intensity sufficient to product an alteration of the neural tissue, the alteration causing the patient to experience a reduction in pain, and a waveform that prevents lethal temperature elecation of the neural tissue during application of the electromagnetic signal to the neural tissue.

Description

RELATED APPLICATION

This application is a continuation of application Ser. No. 08/671,927 filed on Jun. 27, 1996, now U.S. Pat. No. 5,983,141.

BACKGROUND OF THE INVENTION

The use of radiofrequency (rf) generators and electrodes to be applied near or in neural tissue for pain relief or functional modification is well known. For instance, the RFG3C RF Lesion Generator of Radionics, Inc., Burlington, Mass., and its associated electrodes enable placement of the electrode near neural tissue and heating of that tissue by rf resistive power dissipation of the generator power in the tissue. Thermal monitoring by thermo sensor in the electrode has been used to control the process. Heat lesions with tissue temperatures of 60 to 95 degrees Celsius (° C.) are common. tissue dies by heating at about 45 to 50° C., so this process is a heat lesion generation and is designed to elevate the neural tissue above this lethal temperature threshold. Often, the procedure of heating above 45 to 50° C. causes severe pain to the patient which is so unpleasant and frequently unbearable that local or general anesthetic is required during the heat procedure. Use of such anesthetics has a degree of undesired risk to the patient, and the destructive nature of and unpleasant side effects of the rf heat lesion are limitations of this technique, which is well known. Heat lesion generators typically use continuous wave rf generators with radiofrequencies of between 100 KiloHertz to several MegaHertz (viz. the rf generators of Radionics, Fischer, OWL, Elekta, Medtronic, Osypka, EPT companies). The theory and use of rf lesion generators and electrodes for pain and functional disorders is described in various papers; specifically see: (1) Cosman, et al. “Theoretical Aspects of Radiofrequency Lesions and the Dorsal Root Entry Zone.” Neurosurg 15:945-950, 1984; and (2) Cosman E R and Cosman B J. “Methods of Making Nervous System Lesions,” in Wilkins R H, Rengachary S S (eds): Neurosurgery. New York, McGraw-Hill, Vol. III, 2490-2498, 1984.

Neural stimulation is also now a common method of pain therapy. Stimulus generators with outputs of 0 to 10 volts (or zero to several milliamperes of current criteria are used) are typical. A variety of waveforms and pulse trains in the “physiologic” frequency ranges of 0 to about 300 Hertz are also typical. This output is delivered to electrodes placed near or in neural tissue on a temporary basis (acute electrode placement) or permanent basis (chronic electrode implants). Such stimulation can relieve pain, modify neural function, and treat movement disorders. Typically, the stimulation is sustained to have a long-term effect, i.e. usually when the stimulus is turned off, the pain will return or the therapeutic neural modification will cease after a short time (hours or days). Thus permanent implant electrodes and stimulators (battery or induction driven) is standard practice (viz. see the commercial systems by Medtronic, Inc., Minneapolis, Minn.), and the stimulus is usually sustained or repeated on an essentially continuous basis for years to suppress pain or to treat movement disorders (viz. Parkinsonism, bladder control, spasticity, etc.). Stimulators deliver regular pulse trains or repetitive bursts of pulses in the range of 0 to 200 Hertz (i.e., a physiologic range similar to the body's neural frequency pulse rates), so this method simulates or inhibits neural function at relatively low frequency. It does not seek to heat the neural tissue for destructive purposes as in high frequency technique. Chronically or permanently implanted stimulators often require battery changes or long-term maintenance and patient follow-up, which is expensive and inconvenient, often requiring repeated surgery.

Electrosurgical generators have been in common use for decades cutting and coagulating tissue in surgery. They typically have a high frequency, high power generator connected to an electrode that delivers a high power output to explode tissue for tissue cutting and to cook, sear, and coagulate tissue to stop bleeding. Examples are the generators of Codman, Inc., Randolph Mass., Valley Labs, Inc., Boulder, Colo., and EMC Industries, Montrouge, France. Such generators have high frequency output waveforms which are either continuous waves or interrupted or modulated waves with power controls and duty cycles at high levels so that tissue at the electrode is shattered and macroscopically separated (in cutting mode) or heated to very high temperatures, often above cell boiling (100° C.) and charring levels (in coagulation or cauterizing mode). The purpose of electrosurgery generators is surgical, not therapeutic, and accordingly their output controls, power range, duty cycle, waveforms, and monitoring is not designed for gentle, therapeutic, neuro-modulating, sub-lethal temperature application. Use of an electrosurgical unit requires local or general anesthetic because of its violent and high-temperature effect on tissues.

SUMMARY OF THE INVENTION

The present invention is directed to a modulated high frequency apparatus in conjunction with a signal applicator (for example an electrode or conductive plate or structure applied to the body) to modify neural function, the associated apparatus and method of use being functionally different from and having advantages over the rf heat lesioning systems, or the stimulation systems, and electrosurgical systems of the type described above. Pain relief or neural modification, for instance, can be achieved by the present invention system without average heating of tissue above 45 to 50° C., without stimulating at frequencies in the range of 0 to about 300 Hertz and without burning or cauterizing tissue. Thus as one advantage of the present invention, painful rf lesioning episodes at high lesion temperatures can be avoided and the need for chronic stimulation can be circumvented.

For example, by using an rf waveform output connected to an electrode inserted into the body near or in neural tissue, and by interrupting the rf waveform with bursts of rf power with interposed periods of off-time, a pain relieving effect or other neural modulating effect is accomplished, but the tissue temperature may not on average exceed approximately 45° C. This avoids the painful heat lesions associated with the typical rf lesions which involve tissue temperatures at a region near the electrode of substantially greater than 45° C. The modulated rf system can be used painlessly and easily, avoiding usual discomforts of standard rf heating procedures, yet relief of the pain or the neural disfunction (such as for example motor disfunction, spasticity, Parkinsonism, tremors, modd disorders, incontinence, etc.) can be long lasting using the novel system of the present invention, giving results in many cases that are comparable to those of rf heat lesions done at much higher temperatures. Some applications of this invention may include such examples as relief of back, head, and facial pain by procedures such as dorsal root ganglion or trigeminal ganglion treatments, spinal cord application for relief of intractable pain, spasticity, or motor control, treatment of the basal ganglia in the brain for relief of Parkinsonism, loss of motor control, tremors, or intractible pain. This pain relief or control or elimination of motor or other neural disfunction can be comparable if not more effective than long-term stimulators with implanted electrodes, thus avoiding the need for permanent implants, expensive implanted devices and circuits, battery changes, involving repeated surgery and expense, and repeated application of stimulation energy over long periods (months and years). The pain relief or neural modification can be accomplished by the present invention in a non-violent, painless way, avoiding average tissue temperature elevations into the lethal range and violent macroscope tissue separations, and thus the present invention is opposite to the objectives, systems, and methods involved in electrosurgical systems.

Forms of the modulated frequency generator and output waveforms are disclosed herein in various embodiments. Specific embodiments with temperature monitors and thermal sensing electrodes are disclosed which are suited to control the modulated system and its use.

BRIEF DESCRIPTION OF THE DRAWINGS

In the drawings, which constitute a part of the specification, exemplary embodiments exhibiting various forms and features hereof are set forth, specifically:

FIG. 1 is a block diagram of elements of a system in accordance with the present invention.

FIG. 2 is a graphical representation of an interrupted rf waveform output from an rf generator system in accordance with the present invention.

FIG. 3 shows a graph of a modulated frequency waveform of the present invention.

FIG. 4 illustrates an irregular frequency output waveform in accordance with the present invention.

FIG. 5 shows a repeated frequency signal with lowered output duty cycle.

FIG. 6 is a block diagram of elements of a system for generating modulated frequency signals.

DESCRIPTION OF THE INVENTION

Referring to FIG. 1, an illustration of the present invention is shown in block diagram and schematic elements. An electrode with uninsulated conductive surface 1 (for example a conductive tip end) is in proximity to a region of neural tissue NT (viz. illustrated schematically by the dashed boundary). The electrode has an insulated shaft 2 and connection or hub portion 3, inside of which there can be electric connections to surface 1. Connection 10 electrically connects to the surface 1 through the electrode shaft 2 and to electronic supply units 4 and 5 (which are shown outside the body, but which may be miniaturized and implanted inside the body). Element 5 is a signal generator of signal output (viz., voltage, current, or power), and element 4 is a modulator to modulate (for example the amplitude of) the high frequency output from 4. The electromagnetic output from 4 and 5 is connected to electrode surface 1, and therefore is conductively exposed to tissue NT. As an example, element 5 can take the form of an rf power source with a continuous wave output (viz. for example, similar to the model RFG-3C generator of Radionics, Inc., Burlington, Mass.). Element 4 is a pulse modulation unit which switches on and off the rf output from 5 at a designed rate and duty cycle. RF output generators or supplies and, modulation circuits are known in high frequency technique (viz. Radio Engineering by Fredereck E. Terman, McGraw-Hill, New York, 1947, 3rd Edition). Further shown is a temperature monitoring element or circuit 6 which connects by cable 11 to the electrode and to a thermal sensor (viz. thermistor or thermocouple) inside the electrode applicator or conductive tip 1 to measure the temperature of the tissue NT near the tip. (Such thermal sensing circuits and electrodes are illustrated by the Model RFG-3C and associated thermal-sensing, rf electrodes of Radionics, Inc., Burlington, Mass.). Further, reference electrode 8 is shown in electric contact to the patient's body B with connection wire 12 to generator 5 so as to provide a circuit for return current from electrode applicator 1 through the patient B (such reference electrodes are common with rf lesion generators; see Cosman, et al., 1984). Element 7 is a switch or circuit breaker which illustrates that such a return circuit could be opened to limit such direct return current, and limit such current to inductive or reactive current characteristic of time varying circuits such as rf circuits.

In operation, the voltage or current output from generator 4 and modulator 5 are impressed upon tissue NT, which may be neural tissue (viz. spinal nerves or roots, spinal cord, brain, etc.) or tissue near neural tissue. In accordance with the present invention, such electromagnetic output can cause energy deposition, electric field effects, and/or electromagnetic field effects on the nerve cells in the tissue NT so as to modify or destroy the function of such nerve cells. For example, such modification of neural function may include reduction or elimination of pain syndromes (such as spinal facet, mechanical back pain, facial pain) in some cases, alleviating motor disfunction, spasticity, Parkinsonism, etc., epilepsy or mood disorders. Because the rf output from 4 is modulated by element 5, its percent on-time is reduced so that sustained heating of tissue NT is reduced, yet the neural therapeutic effects of the impressed rf voltages and currents on the neural tissue NT are enough to produce the pain reducing result. The generator 5 can have a power, voltage, or current output control 5A (as on the Radionics Model RFG-3C rf generator) to increase or decrease the output power magnitude or modulated duty cycle to prevent excessive heating of tissue NT or to grade the level of pain interruption as needed clinically. Output control 5A may be a knob which can raise or lower the output in a smooth, venerated way, or it can be an automatic power control with feedback circuits. In this regard, temperature monitor 6 can provide the operator with the average temperature of tissue NT near electrode tip 1 to interactively prevent temperatures near tip 1 to exceed the range of approximately 45° C. (on average thermally lethal to tissue NT), and thus to avoid the higher temperature ranges for the usual heat lesioning procedures described above. For example, 6 may have feedback circuitry to change the modulation duty cycle (by, for example, longer or shorter on-times) to hold the temperature near tissue NT to below a set value (viz. 40 to 45° C.), illustrated by the feedback line 14 in FIG. 1. In addition, the high frequency waveform from the generator 5 can be free from substantial components in the 0 to about 300 to 400 Hertz range (which is much lower than radiofrequencies), and this will avoid the stimulation effects that are typical for stimulator system applications as described above.

As an example of a modulated rf waveform that accommodates the system of the present invention, FIG. 2 shows schematically a high frequency output of voltage amplitude V and of burst duration T1 between which on-time bursts there are illustrated periods of zero voltage of duration T2. During the on-time T1, the rf signal output is oscillatory with time period T3 between maximum voltages V. The reciprocal of T3 is proportional to the value of the radiofrequency (viz., 1 Mega Hertz rf output corresponds to T3=1 microsecond). This is an interrupted or bursting type of modulated high frequency waveform. During the high frequency on-time T1, the voltage can oscillate between plus and minus its maximum value V. Accordingly, an electric field is produced around the region of the electrode applicator (as for instance the exposed electrode tip 1 in FIG. 1). The electric field has a modifying, or pain-relieving, or neural-altering effect on the tissue near or among the nerve cells and fibers. Pain relief and neural modification can accordingly be accomplished by this high frequency bursting voltage and accompanying electromagnetic field, and also accompanying current among the neural and tissue cells. During the off period, there is minimal or no voltage (i.e. V=0 at the electrode applicator), and thus no electric field or electric currents in and among the neural tissue. During that period, no heat deposition is present. Thus, over the entire cycle, from on period T1 through off period T2, the energy deposition, on average, can be adjusted so that there is not excessive heating, on average, around the electrode applicator. Thus, the usual mechanism of continuous on-time high frequency voltage and current, as in previous heat lesion techniques, is avoided, and therefore the achievement of high average temperatures near or around the applicator tip may be eliminated by the present invention. The usual heat lesion process in which tissue temperatures, on average, exceed 45° can be avoided. In many instances, this avoidance of high temperature domains due to high average heat dissipation of the radiofrequency power will prevent acute pain of the process to the patient. By having the interrupted waveform, as in FIG. 2, the average power is thereby reduced and the average heating around the electrode tip or applicator is accordingly reduced. However, substantial voltages V (or currents) can still be sustained during the on period with their resulting therapeutic effect on the tissue.

To give a representative example of values for parameters in an interrupted high frequency waveform as in FIG. 2, the overall pattern of the waveform may have a total period of one second, meaning that the sum of T1+T2=1 second. The on period T1 can be 20 milliseconds, and the off period T2, therefore, can be 980 milliseconds. Voltages V in the range of 10 to 30) volts or more can be used. It can be used with a pain relieving effect in certain tissues. Average tip temperature around an electrode tip such as the exposed tip element 1 in FIG. 1 can be maintained at or below 40° C., well below thermo-lethal levels. Electrodes with diameters of 1 or 2 mm shaft (for example the shaft 2 of a cannula in FIG. 1), with an exposed tip of 1 to 10 mm (such as the tip element 1 in FIG. 1) can be used and the electrode can be inserted in around neural structures in the brain or peripheral nerves or peripheral nerve ganglia to accomplish pain relief or other neurological alteration. Variation of these parameters can be made with similar therapeutic effect, and various geometries of conductive electrode or applicator can be effective. Illustrations of a wide variety of such electrodes are illustrated by the product line of Radionics, Inc., Burlington, Mass. Pointed or sharpened electrodes (such as illustrated schematically by electrode tip 1 in FIG. 1) are useful for penetration of the electrode through the skin to the target neural tissue site, and electric or current fields of higher intensity will be present at a sharpened point for a given applied voltage (such as V in FIG. 2), which will be effective in altering neural function.

FIG. 3 shows a variation of modulated high frequency waveform which accomplishes high peak voltage swings with reduced average power deposited in tissue. The baseline voltage may be put at zero (viz. V=0), shown by dashed line 24. The solid line 21 represents the actual waveform, which has rapid oscillations at the radiofrequency and has an overall enveloped represented by dashed line 20, that has high points and low points with an approximate on time T1 and a time period between envelope of modulation maxima T2, T1, again, could be a percentage on time of 2 percent (as described above for 20 milliseconds on time out of 1 second total), and this on time T1 may vary considerably while still maintaining substantial off time so as to prevent overall average high temperature heating (as in the usual rf heat lesion systems). Such a modulation envelope (as dashed line 20) can be achieved by using a modulated signal generator that varies the input or output gain of a high frequency generator (as element 5 in FIG. 1) so as to achieve such a waveform is in FIG. 3. In such circuitry, which is commonly used in pulse generation techniques, low frequency filtering or selection of modulation parameters can avoid stimulation voltage or current components at the physiologic range of 0 to 300 Hertz so that unpleasant stimulative effects can be avoided during the therapeutic intermittent high frequency lesion process.

FIG. 4 shows yet another embodiment of an interrupted high frequency waveform in accordance with the present invention. Here there is a non-periodic variation of the voltage represented by the excursions of the voltage V represented by excursions on a vertical axis. The maxima point 25 can occur at random positions in time. The time difference between maxima can also vary in an irregular or even random way. This waveform may have no repeating or periodic structure but may be analogous to high frequency noise with random amplitudes, peaks, zero crossings, and carrier high frequencies. Such a waveform can be generated by random noise generators, spark gap signals, or other noisy signals that are known in the field of signal generation (viz. Radio Engineering, cited above). Filtering can be applied in the wave generator and power amplifier so that lower frequencies in the physiologic range will not be present to give undesirable stimulation effects.

FIG. 5 shows yet another possible high frequency waveform of interrupted, repeated bipolar pulses with frequency repetitive T3 for example the physiologic stimulation frequency range (i.e., 0 to about 300 Hertz). The pulse on-time may be low enough so that the power deposition can be kept low enough to prevent heating, and yet the peak voltage V is enough to alter the neural function.

Variations of such waveforms are possible with the same intermittent high frequency effect for pain on neurological modification. For instance, a baseline V=0 may not pertain and a slowly varying baseline of non-zero value can be used. The time average of the signal need not be zero. The on and off switching of a high frequency signal such as in FIG. 2 can be done at a non-periodic or nonregular, repeating rate so that, on average, the polarization effects in the tissue are still maintained at a low level. The average power deposition can still be maintained at a low level with non-periodic, interrupted high frequency waveforms. The high frequency carrier frequency (i.e. represented by the inverse of time T3 in FIG. 2 and FIG. 3) may also be non-constant. Varying or combined or superposed high frequency waveforms can be used as the carriers, and these combined or composite high frequency waveforms can be interrupted or modulated in accordance with the present system and invention. Pulse waveforms with high frequency carriers can be shaped in a variety of ways, for example with fast rising leading edges and slow or falling off or exponential trailing edges. The signal generator waveform can have a peak intensity which is much higher than the average or RMS intensity to yield a high electromagnetic field or current density on the neural tissue while maintaining the average power deposition in the tissue at a sufficiently low level to prevent heating above lethal tissue temperatures (viz. 40 to 50° C.).

FIG. 6 shows a block diagram of a system for generating modulated high frequency signals (similar but in more detail to the block element of high frequency generator 5 and modulator 4 of FIG. 1).

Element 50 represents a signal generator which may create a high frequency signal of periodic or non-periodic frequency. This has input to element 31, which is a filter system which selectively filters out frequencies that could cause unpleasant, undesired, or damaging physiological signals. The signal is then fed into element 33, which is a waveform shaping circuit, and will shape the waveform input from element 32, which provides amplified modulation and/or frequency modulation and/or phase modulation control. Circuits of this type can be found, for instance in Radio Engineering by Terman (cited above). Additional waveform shaping can be done by element 40 and 41, which can control the amplitude of waveform and/or the duty cycle of the waveform, respectively. This resultant signal is then fed into a power amplifier represented of element 34. This is a wide band amplifier used to increase the signal to power levels appropriate for clinical use. This energy is then delivered to the patient via an electrode depicted as element 35.

A temperature sensor or plurality of temperature sensors, represented by element 36, can also be placed and connected in proximity to this electrode so as to insure that the temperature does not exceed desired limits. This temperature sensor signal is fed through element 37, which is a special filter module used to eliminate high frequency components, and thus not to contaminate the low-level temperature signals.

The temperature signal is fed to element 38, which is a standard temperature measuring unit that converts the temperature signal into a signal that can be used to display temperature and/or to control, in a feedback manner, either the amplitude and/or the duty cycle of the high frequency waveform. In this way, power delivery can be regulated to maintain a given set temperature. This flow is represented by element 39, which is simply a feedback control device. The dotted lines from element 39 to elements 40 and 41 represent a feedback connection that could either be electronic and/or mechanical. It could also simply be a person operating these controls manually, based on the visual display of temperature, as for example on a meter or graphic display readout 42.

As was explained with respect to the disclosed embodiments, many variations of circuit design, modulated high frequency waveforms, electrode applicators, electrode cannulas will be appreciated by those skilled in the art for example, electrodes or electrode applicators are practical, including tubular shapes, square shafts, flat electrodes, area electrodes, multiple electrodes, arrays of electrodes, electrodes with side outlets or side-issued tips, electrodes with broad or expandable or conformal tips, electrodes that can be implanted in various portions of the brain, spinal cord, interfecal space, interstitial or ventricular spaces, nerve ganglia can be considered within the system of the present invention.

The frequency range for the so-called high frequency waveforms, as shown for instance in FIGS. 2, 3, 4, and 5 can be used over a wide range. For example, the “high frequency” characteristic of 1/T3, which may be only one of many high frequency components, can be above the so-called physiologic stimulation frequency range of 0 to about 300 Hertz. This high frequency may also range up into the radiofrequency or microwave range (viz. 50 Kilo Hertz to many Mega Hertz).

Mixtures of frequencies can be done as discussed above. These could be admixtures of “high frequencies” (above the physiologic stimulation range (say 0 to 300 Hertz) and lower frequencies (within that stimulation range of say 0 to 300 Hertz). Thus one skilled in the art could have both modulated high frequency and stimulation frequencies for various clinical effects, such as stimulation blockage of pain while neural modification is being applied according to the present invention.

In view of these considerations, as will be appreciated by persons skilled in the art, implementations and systems should be considered broadly and with reference to the claims set forth below.

Claims (40)

1. A method for sustained neural function modification in a patient comprising:
generating an amplitude modulated signal having at least one frequency component above a physiologic stimulation frequency range; and
applying the amplitude modulated signal to selected neural tissue in the patient for altering a function of the tissue without heating the tissue to temperatures lethal to the tissue, wherein said amplitude modulated signal has a peak voltage, said peak voltage being sufficient to alter the function of the tissue in the patient, wherein the function remains altered for a given period of time after application of the signal to the tissue is ceased.
2. The method of claim 1 wherein altering the function of the tissue reduces pain experienced by the patient.
3. The method of claim 1 wherein altering the function of the tissue reduces pain by tremor experienced by the patient.
4. The method of claim 1 wherein altering the function of the tissue reduces symptoms of Parkinson's disease experienced by the patient.
5. The method of claim 1 wherein altering the function of the tissue reduces symptoms of spasticity experienced by the patient.
6. The method of claim 1 wherein altering the function of the tissue reduces symptoms of mood disorder experienced by the patient.
7. The method of claim 1 wherein altering the function of the tissue reduces symptoms of epilepsy experienced by the patient.
8. The method of claim 1 wherein altering the function of the tissue alleviates motor disfunction.
9. The method of claim 1 wherein the at least the frequency component of the amplitude modulated signal alters the function of the tissue.
10. The method of claim 1 wherein applying the amplitude modulated signal to the tissue comprises engaging the tissue with an electrode coupled with a signal generator generating the amplitude modulated signal.
11. The method of claim 1 wherein temperatures lethal to the tissue are greater than 45° C.
12. The method of claim 1 wherein the at least one frequency component has a frequency greater than 300 Hz.
13. An apparatus for sustained alteration of a function of selected neural tissue in a patient comprising
a signal generator and an electrode coupled to the signal generator, said signal generator being adapted to generate an amplitude modulated signal having at least one frequency component above a physiologic stimulation frequency range, said electrode being adapted to apply the signal to the tissue, wherein application of the amplitude modulated signal to the tissue alters a function of the tissue while inhibiting heating of the tissue to temperatures lethal to the tissue, wherein said amplitude modulated signal has a peak voltage, said peak voltage being sufficient to alter the function of the tissue in the patient, and wherein alteration of the function of the tissue persists even after application of the signal to the tissue ceases.
14. The apparatus of claim 13 wherein altering the function of the tissue reduces pain experienced by the patient.
15. The apparatus of claim 13 wherein altering the function of the tissue causes the patient to experience a reduction in pain by tremor.
16. The apparatus of claim 13 wherein altering the function of the tissue causes the patient to experience reduced symptoms of Parkinson's disease.
17. The apparatus of claim 13 wherein altering the function of the tissue causes the patient to experience a reduced symptoms of spasticity.
18. The apparatus of claim 13 wherein altering the function of the tissue causes the patient to experience a reduced symptoms of mood disorder.
19. The apparatus of claim 13 wherein altering the function of the tissue causes the patient to experience a reduced symptoms of epilepsy.
20. The apparatus of claim 13 wherein altering the function of the tissue alleviates motor disfunction.
21. The apparatus of claim 13 wherein the at least one frequency component of the amplitude modulated signal alters the function of the tissue.
22. A method for lasting modification of neural tissue function in a patient comprising:
placing an electrode in or near selected neural tissue of the patient;
generating an amplitude modulated signal and transmitting the signal to the electrode, said signal having at least one frequency component above a physiologic stimulating frequency range for alteration of a function of the tissue without heating the tissue to temperatures lethal to the tissue, wherein said amplitude modulated signal has a peak voltage being sufficient to alter the function of the tissue in the patient, said alteration being sustained even after transmission of the signal to the electrode ceases.
23. The method of claim 22 wherein altering the function of the tissue reduces pain experienced by the patient.
24. The method of claim 22 wherein altering the function of the tissue causes the patient to experience a reduction in pain by tremor.
25. The method of claim 22 wherein altering the function of the tissue causes the patient to experience reduced symptoms of Parkinson's disease.
26. The method of claim 22 wherein altering the function of the tissue causes the patient to experience a reduced symptoms of spasticity.
27. The method of claim 22 wherein altering the function of the tissue causes the patient to experience a reduced symptoms of mood disorder.
28. The method of claim 22 wherein altering the function of the tissue causes the patient to experience a reduced symptoms of epilepsy.
29. The method of claim 22 wherein altering the function of the tissue alleviates motor disfunction.
30. The method of claim 22 wherein the at least one frequency component of the amplitude modulated signal alters the function of the tissue.
31. The method of claim 22 wherein temperatures lethal to the tissue are greater than 45° C.
32. The method of claim 22 wherein the at least one frequency component has a frequency greater than 300 Hz.
33. A method for sustained neural function modification in a patient comprising:
generating interrupted radiofrequency waveforms having predetermined time periods of on-time bursts of radiofrequency output of a first predetermined duration followed by relatively substantial off-time periods of very low output at a second predetermined duration; and
applying the interrupted radiofrequency waveforms to selected neural tissue in the patient for a predetermined treatment time sufficient to result in alteration of a function of the tissue without heating the tissue to temperatures lethal to the tissue, wherein the interrupted radiofrequency waveforms have a peak voltage sufficient to result in said alteration, wherein the function remains altered for a given period of time after application of the signal to the tissue is ceased.
34. The method of claim 33, wherein altering the function of the tissue reduces symptoms experienced by the patient selected from the group consisting of pain, tremor, Parkinson's disease, spasticity, mood disorder, epilepsy, and motor dysfunction.
35. The method of claim 33, wherein the step of applying the interrupted radiofrequency waveforms to the tissue includes engaging the tissue with an electrode coupled with a signal generator.
36. The method of claim 33, wherein the generating step includes having a ratio of on-time bursts of radiofrequency output to off-time bursts of approximately two percent.
37. An apparatus for sustained alteration of a function of selected neural tissue in a patient comprising:
a signal generator which generates interrupted radiofrequency waveforms having predetermined time periods of on-time bursts of radiofrequency output of a first predetermined duration followed by relatively substantial off-time periods of very low output at a second predetermined duration,
an electrode coupled to the generator and being adapted to apply the interrupted radiofrequency waveforms to the tissue, wherein application of the interrupted radiofrequency waveforms to the tissue alters a function of the tissue while inhibiting heating of the tissue to temperatures lethal to the tissue, wherein the interrupted radiofrequency waveforms have a peak voltage, said peak voltage being sufficient to result in said alteration, and wherein alteration of the function of the tissue persists even after application of the signal to the tissue ceases.
38. The apparatus of claim 37, wherein altering the function of the tissue reduces symptoms experienced by the patient selected from the group consisting of pain, tremor, Parkinson's disease, spasticity, mood disorder, epilepsy, and motor dysfunction.
39. The apparatus of claim 37, wherein the generator is adapted to apply the interrupted radiofrequency waveforms to the tissue in a ratio of on-time bursts of radiofrequency output to off-time bursts of approximately two percent.
40. An apparatus for sustained alteration of a function of selected neural tissue in a patient comprising:
a signal generator which generates interrupted radiofrequency waveforms having predetermined time periods of on-time bursts of radiofrequency output of a first predetermined duration followed by relatively substantial off-time periods of very low output at a second predetermined duration;
an electrode coupled to the generator and being adapted to apply the interrupted radiofrequency waveforms to the tissue by being surgically inserted in or on the patient, wherein application of the interrupted radiofrequency waveforms to the tissue alters a function of the tissue while inhibiting heating of the tissue to temperatures lethal to the tissue, and wherein alteration of the function of the tissue persists even after application of the signal to the tissue ceases, and wherein the interrupted radiofrequency waveforms have a peak voltage sufficient to alter the neural tissue, and wherein said peak voltage is in a range that includes tens of volts.
US10460506 1996-06-27 2003-06-12 Method and apparatus for altering neural tissue function Expired - Fee Related USRE41045E1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US08671927 US5983141A (en) 1996-06-27 1996-06-27 Method and apparatus for altering neural tissue function
US09410609 US6259952B1 (en) 1996-06-27 1999-10-01 Method and apparatus for altering neural tissue function
US10460506 USRE41045E1 (en) 1996-06-27 2003-06-12 Method and apparatus for altering neural tissue function

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10460506 USRE41045E1 (en) 1996-06-27 2003-06-12 Method and apparatus for altering neural tissue function

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09410609 Reissue US6259952B1 (en) 1996-06-27 1999-10-01 Method and apparatus for altering neural tissue function

Publications (1)

Publication Number Publication Date
USRE41045E1 true USRE41045E1 (en) 2009-12-15

Family

ID=24696456

Family Applications (3)

Application Number Title Priority Date Filing Date
US08671927 Expired - Lifetime US5983141A (en) 1996-06-27 1996-06-27 Method and apparatus for altering neural tissue function
US09410609 Expired - Lifetime US6259952B1 (en) 1996-06-27 1999-10-01 Method and apparatus for altering neural tissue function
US10460506 Expired - Fee Related USRE41045E1 (en) 1996-06-27 2003-06-12 Method and apparatus for altering neural tissue function

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US08671927 Expired - Lifetime US5983141A (en) 1996-06-27 1996-06-27 Method and apparatus for altering neural tissue function
US09410609 Expired - Lifetime US6259952B1 (en) 1996-06-27 1999-10-01 Method and apparatus for altering neural tissue function

Country Status (6)

Country Link
US (3) US5983141A (en)
EP (1) EP0959944B1 (en)
CA (1) CA2272125A1 (en)
DE (1) DE69740073D1 (en)
ES (1) ES2355462T3 (en)
WO (1) WO1997049453A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090274471A1 (en) * 2008-04-30 2009-11-05 General Instrument Corporation Method and apparatus for controlling the optical output power from a burst mode laser
US20110144634A1 (en) * 2005-08-02 2011-06-16 Neurotherm, Inc. Method and Apparatus for Diagnosing and Treating Neural Dysfunction

Families Citing this family (256)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6023638A (en) 1995-07-28 2000-02-08 Scimed Life Systems, Inc. System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue
US6302875B1 (en) 1996-10-11 2001-10-16 Transvascular, Inc. Catheters and related devices for forming passageways between blood vessels or other anatomical structures
US6161048A (en) * 1997-06-26 2000-12-12 Radionics, Inc. Method and system for neural tissue modification
USRE40279E1 (en) 1997-06-26 2008-04-29 Sherwood Services Ag Method and system for neural tissue modification
US6246912B1 (en) * 1996-06-27 2001-06-12 Sherwood Services Ag Modulated high frequency tissue modification
US5983141A (en) * 1996-06-27 1999-11-09 Radionics, Inc. Method and apparatus for altering neural tissue function
US6231565B1 (en) 1997-06-18 2001-05-15 United States Surgical Corporation Robotic arm DLUs for performing surgical tasks
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US6021343A (en) 1997-11-20 2000-02-01 Surgical Navigation Technologies Image guided awl/tap/screwdriver
WO1999038567A1 (en) * 1998-01-29 1999-08-05 Baldi Holding S.A. Muscle electrostimulator conformed in such a way as to avoid sensations of pain and reddening of the skin
US6493588B1 (en) 1998-03-18 2002-12-10 Mmc/Gatx Partnership No. 1 Electro-nerve stimulator systems and methods
US6107699A (en) 1998-05-22 2000-08-22 Scimed Life Systems, Inc. Power supply for use in electrophysiological apparatus employing high-voltage pulses to render tissue temporarily unresponsive
US6428537B1 (en) 1998-05-22 2002-08-06 Scimed Life Systems, Inc. Electrophysiological treatment methods and apparatus employing high voltage pulse to render tissue temporarily unresponsive
WO1999062599A1 (en) * 1998-06-02 1999-12-09 Amir Oron Ischemia laser treatment
US6482182B1 (en) 1998-09-03 2002-11-19 Surgical Navigation Technologies, Inc. Anchoring system for a brain lead
US7901400B2 (en) 1998-10-23 2011-03-08 Covidien Ag Method and system for controlling output of RF medical generator
US7137980B2 (en) 1998-10-23 2006-11-21 Sherwood Services Ag Method and system for controlling output of RF medical generator
US6436129B1 (en) * 1999-01-20 2002-08-20 Oratec Interventions, Inc. Method and apparatus for stimulating nerve regeneration
US6505075B1 (en) 1999-05-29 2003-01-07 Richard L. Weiner Peripheral nerve stimulation method
US7364577B2 (en) 2002-02-11 2008-04-29 Sherwood Services Ag Vessel sealing system
US8644907B2 (en) 1999-10-28 2014-02-04 Medtronic Navigaton, Inc. Method and apparatus for surgical navigation
US20070129746A1 (en) * 1999-12-09 2007-06-07 Mische Hans A Methods and devices for the treatment of neurological and physiological disorders
US7896872B2 (en) * 1999-12-21 2011-03-01 Philip Michael Finch Apparatus for thermal treatment of an intervertebral disc
DE60112886D1 (en) 2000-01-07 2005-09-29 Biowave Corp Apparatus for electrotherapy
US7013179B2 (en) * 2000-01-07 2006-03-14 Biowave Corporation Percutaneous electrode array
US20080033492A1 (en) * 2000-01-07 2008-02-07 Biowave Corporation Electro-therapy method
US6853864B2 (en) 2000-02-02 2005-02-08 Catholic University Of America, The Use of electromagnetic fields in cancer and other therapies
US7587230B2 (en) * 2000-02-02 2009-09-08 The Catholic University Of America Method of using magnetic fields to uniformly induce electric fields for therapeutic purposes
CA2397413C (en) 2000-02-03 2011-04-05 Baylor College Of Medicine Methods and devices for intraosseous nerve ablation
US6944501B1 (en) * 2000-04-05 2005-09-13 Neurospace, Inc. Neurostimulator involving stimulation strategies and process for using it
BE1013664A3 (en) * 2000-08-30 2002-06-04 Declercq Henri Nerve stimulation device.
DE60035378T2 (en) * 2000-09-07 2008-02-28 Covidien Ag Device for the treatment of intervertebral discs
US6535764B2 (en) * 2001-05-01 2003-03-18 Intrapace, Inc. Gastric treatment and diagnosis device and method
US6636757B1 (en) 2001-06-04 2003-10-21 Surgical Navigation Technologies, Inc. Method and apparatus for electromagnetic navigation of a surgical probe near a metal object
US20050203578A1 (en) * 2001-08-15 2005-09-15 Weiner Michael L. Process and apparatus for treating biological organisms
US20030093007A1 (en) * 2001-10-17 2003-05-15 The Government Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Serv Biopsy apparatus with radio frequency cauterization and methods for its use
US8812114B2 (en) 2001-10-18 2014-08-19 Uroplasty, Inc. Lead set for nerve stimulator and method of operation thereof
ES2450465T3 (en) 2001-10-18 2014-03-24 Uroplasty, Inc. Electrostimulation nervous system
US20030144712A1 (en) * 2001-12-20 2003-07-31 Jackson Streeter, M.D. Methods for overcoming organ transplant rejection
US20030109906A1 (en) * 2001-11-01 2003-06-12 Jackson Streeter Low level light therapy for the treatment of stroke
US7303578B2 (en) 2001-11-01 2007-12-04 Photothera, Inc. Device and method for providing phototherapy to the brain
US20040132002A1 (en) * 2002-09-17 2004-07-08 Jackson Streeter Methods for preserving blood
US7316922B2 (en) * 2002-01-09 2008-01-08 Photothera Inc. Method for preserving organs for transplant
US6947786B2 (en) 2002-02-28 2005-09-20 Surgical Navigation Technologies, Inc. Method and apparatus for perspective inversion
US8043287B2 (en) 2002-03-05 2011-10-25 Kimberly-Clark Inc. Method of treating biological tissue
US7294127B2 (en) * 2002-03-05 2007-11-13 Baylis Medical Company Inc. Electrosurgical tissue treatment method
US8882755B2 (en) 2002-03-05 2014-11-11 Kimberly-Clark Inc. Electrosurgical device for treatment of tissue
US8518036B2 (en) 2002-03-05 2013-08-27 Kimberly-Clark Inc. Electrosurgical tissue treatment method
US20050177209A1 (en) * 2002-03-05 2005-08-11 Baylis Medical Company Inc. Bipolar tissue treatment system
US6896675B2 (en) 2002-03-05 2005-05-24 Baylis Medical Company Inc. Intradiscal lesioning device
US6990368B2 (en) 2002-04-04 2006-01-24 Surgical Navigation Technologies, Inc. Method and apparatus for virtual digital subtraction angiography
US20060206150A1 (en) 2002-04-08 2006-09-14 Ardian, Inc. Methods and apparatus for treating acute myocardial infarction
US20080213331A1 (en) 2002-04-08 2008-09-04 Ardian, Inc. Methods and devices for renal nerve blocking
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US8131371B2 (en) 2002-04-08 2012-03-06 Ardian, Inc. Methods and apparatus for monopolar renal neuromodulation
US20140018880A1 (en) 2002-04-08 2014-01-16 Medtronic Ardian Luxembourg S.A.R.L. Methods for monopolar renal neuromodulation
US6978174B2 (en) 2002-04-08 2005-12-20 Ardian, Inc. Methods and devices for renal nerve blocking
US8145317B2 (en) 2002-04-08 2012-03-27 Ardian, Inc. Methods for renal neuromodulation
US9308043B2 (en) 2002-04-08 2016-04-12 Medtronic Ardian Luxembourg S.A.R.L. Methods for monopolar renal neuromodulation
US20110207758A1 (en) 2003-04-08 2011-08-25 Medtronic Vascular, Inc. Methods for Therapeutic Renal Denervation
US7162303B2 (en) 2002-04-08 2007-01-09 Ardian, Inc. Renal nerve stimulation method and apparatus for treatment of patients
US8145316B2 (en) 2002-04-08 2012-03-27 Ardian, Inc. Methods and apparatus for renal neuromodulation
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US7853333B2 (en) 2002-04-08 2010-12-14 Ardian, Inc. Methods and apparatus for multi-vessel renal neuromodulation
US8347891B2 (en) 2002-04-08 2013-01-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US8774922B2 (en) 2002-04-08 2014-07-08 Medtronic Ardian Luxembourg S.A.R.L. Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods
US7653438B2 (en) 2002-04-08 2010-01-26 Ardian, Inc. Methods and apparatus for renal neuromodulation
US8774913B2 (en) 2002-04-08 2014-07-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for intravasculary-induced neuromodulation
US20070135875A1 (en) 2002-04-08 2007-06-14 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US8150519B2 (en) 2002-04-08 2012-04-03 Ardian, Inc. Methods and apparatus for bilateral renal neuromodulation
US9636174B2 (en) 2002-04-08 2017-05-02 Medtronic Ardian Luxembourg S.A.R.L. Methods for therapeutic renal neuromodulation
US20070129761A1 (en) 2002-04-08 2007-06-07 Ardian, Inc. Methods for treating heart arrhythmia
US9308044B2 (en) 2002-04-08 2016-04-12 Medtronic Ardian Luxembourg S.A.R.L. Methods for therapeutic renal neuromodulation
US7258688B1 (en) 2002-04-16 2007-08-21 Baylis Medical Company Inc. Computerized electrical signal generator
US7998062B2 (en) 2004-03-29 2011-08-16 Superdimension, Ltd. Endoscope structures and techniques for navigating to a target in branched structure
DE60315970T2 (en) 2002-05-06 2008-05-21 Covidien Ag Blood detector for control of an electrosurgical unit
US8613744B2 (en) 2002-09-30 2013-12-24 Relievant Medsystems, Inc. Systems and methods for navigating an instrument through bone
US8808284B2 (en) 2008-09-26 2014-08-19 Relievant Medsystems, Inc. Systems for navigating an instrument through bone
US8361067B2 (en) 2002-09-30 2013-01-29 Relievant Medsystems, Inc. Methods of therapeutically heating a vertebral body to treat back pain
US20160278791A1 (en) 2008-09-26 2016-09-29 Relievant Medsystems, Inc. Intraosseous nerve modulation methods
US6907884B2 (en) 2002-09-30 2005-06-21 Depay Acromed, Inc. Method of straddling an intraosseous nerve
US7044948B2 (en) 2002-12-10 2006-05-16 Sherwood Services Ag Circuit for controlling arc energy from an electrosurgical generator
US7534255B1 (en) 2003-01-24 2009-05-19 Photothera, Inc Low level light therapy for enhancement of neurologic function
US7660623B2 (en) 2003-01-30 2010-02-09 Medtronic Navigation, Inc. Six degree of freedom alignment display for medical procedures
US7258690B2 (en) 2003-03-28 2007-08-21 Relievant Medsystems, Inc. Windowed thermal ablation probe
US7344555B2 (en) 2003-04-07 2008-03-18 The United States Of America As Represented By The Department Of Health And Human Services Light promotes regeneration and functional recovery after spinal cord injury
US7722601B2 (en) 2003-05-01 2010-05-25 Covidien Ag Method and system for programming and controlling an electrosurgical generator system
EP2316328B1 (en) 2003-09-15 2012-05-09 Super Dimension Ltd. Wrap-around holding device for use with bronchoscopes
EP2113189B1 (en) 2003-09-15 2013-09-04 Covidien LP System of accessories for use with bronchoscopes
GB2432323B (en) * 2003-09-30 2007-11-28 Synapse Medical Solutions Ltd Control unit for tissue treatment
WO2005048809A1 (en) 2003-10-23 2005-06-02 Sherwood Services Ag Redundant temperature monitoring in electrosurgical systems for safety mitigation
CA2542798C (en) 2003-10-23 2015-06-23 Sherwood Services Ag Thermocouple measurement circuit
US7396336B2 (en) 2003-10-30 2008-07-08 Sherwood Services Ag Switched resonant ultrasonic power amplifier system
US7131860B2 (en) 2003-11-20 2006-11-07 Sherwood Services Ag Connector systems for electrosurgical generator
US20100016929A1 (en) * 2004-01-22 2010-01-21 Arthur Prochazka Method and system for controlled nerve ablation
EP1706178B1 (en) * 2004-01-22 2013-04-24 Rehabtronics Inc. System for routing electrical current to bodily tissues via implanted passive conductors
GB0402510D0 (en) * 2004-02-05 2004-03-10 Allen John Electric therapy machine
US8764725B2 (en) 2004-02-09 2014-07-01 Covidien Lp Directional anchoring mechanism, method and applications thereof
US7766905B2 (en) 2004-02-12 2010-08-03 Covidien Ag Method and system for continuity testing of medical electrodes
US7780662B2 (en) 2004-03-02 2010-08-24 Covidien Ag Vessel sealing system using capacitive RF dielectric heating
US20070250139A1 (en) * 2004-05-07 2007-10-25 John Kanzius Enhanced systems and methods for RF-induced hyperthermia II
US7510555B2 (en) 2004-05-07 2009-03-31 Therm Med, Llc Enhanced systems and methods for RF-induced hyperthermia
US7627381B2 (en) * 2004-05-07 2009-12-01 Therm Med, Llc Systems and methods for combined RF-induced hyperthermia and radioimmunotherapy
US20050251233A1 (en) * 2004-05-07 2005-11-10 John Kanzius System and method for RF-induced hyperthermia
GB0411610D0 (en) 2004-05-24 2004-06-30 Bioinduction Ltd Electrotherapy apparatus
US20050283148A1 (en) 2004-06-17 2005-12-22 Janssen William M Ablation apparatus and system to limit nerve conduction
US7799021B2 (en) * 2004-08-04 2010-09-21 Kimberly-Clark Inc. Electrosurgical treatment in conjunction with monitoring
US20120277839A1 (en) 2004-09-08 2012-11-01 Kramer Jeffery M Selective stimulation to modulate the sympathetic nervous system
US9205261B2 (en) 2004-09-08 2015-12-08 The Board Of Trustees Of The Leland Stanford Junior University Neurostimulation methods and systems
US7337006B2 (en) * 2004-09-08 2008-02-26 Spinal Modulation, Inc. Methods and systems for modulating neural tissue
US7628786B2 (en) 2004-10-13 2009-12-08 Covidien Ag Universal foot switch contact port
US7937143B2 (en) 2004-11-02 2011-05-03 Ardian, Inc. Methods and apparatus for inducing controlled renal neuromodulation
US8478410B2 (en) * 2005-02-09 2013-07-02 Michael F. Kivlighan Electronic neural resonator
US7587245B2 (en) * 2005-02-09 2009-09-08 Kivlighan Michael F Electronic neural resonator
US9474564B2 (en) 2005-03-31 2016-10-25 Covidien Ag Method and system for compensating for external impedance of an energy carrying component when controlling an electrosurgical generator
WO2007002741A1 (en) 2005-06-28 2007-01-04 Bioness Development, Llc Improvements to an implant, system and method using implanted passive conductors for routing electrical current
US20070021803A1 (en) 2005-07-22 2007-01-25 The Foundry Inc. Systems and methods for neuromodulation for treatment of pain and other disorders associated with nerve conduction
EP1754512A3 (en) * 2005-08-18 2008-03-05 Neurotherm, Inc. Method and apparatus for diagnosing and treating neural dysfunction
US20070066971A1 (en) 2005-09-21 2007-03-22 Podhajsky Ronald J Method and system for treating pain during an electrosurgical procedure
US20070073354A1 (en) 2005-09-26 2007-03-29 Knudson Mark B Neural blocking therapy
US8734438B2 (en) 2005-10-21 2014-05-27 Covidien Ag Circuit and method for reducing stored energy in an electrosurgical generator
US7548779B2 (en) * 2005-11-15 2009-06-16 Alon Konchitsky Microwave energy head therapy
US7947039B2 (en) 2005-12-12 2011-05-24 Covidien Ag Laparoscopic apparatus for performing electrosurgical procedures
US7620451B2 (en) 2005-12-29 2009-11-17 Ardian, Inc. Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
US9168102B2 (en) 2006-01-18 2015-10-27 Medtronic Navigation, Inc. Method and apparatus for providing a container to a sterile environment
EP2289446B1 (en) 2006-01-24 2017-05-31 Covidien AG System for tissue sealing
US8685016B2 (en) 2006-01-24 2014-04-01 Covidien Ag System and method for tissue sealing
CA2574935A1 (en) 2006-01-24 2007-07-24 Sherwood Services Ag A method and system for controlling an output of a radio-frequency medical generator having an impedance based control algorithm
US7513896B2 (en) 2006-01-24 2009-04-07 Covidien Ag Dual synchro-resonant electrosurgical apparatus with bi-directional magnetic coupling
US8216223B2 (en) 2006-01-24 2012-07-10 Covidien Ag System and method for tissue sealing
CA2574934C (en) 2006-01-24 2015-12-29 Sherwood Services Ag System and method for closed loop monitoring of monopolar electrosurgical apparatus
US8147485B2 (en) 2006-01-24 2012-04-03 Covidien Ag System and method for tissue sealing
US9186200B2 (en) 2006-01-24 2015-11-17 Covidien Ag System and method for tissue sealing
US7575589B2 (en) 2006-01-30 2009-08-18 Photothera, Inc. Light-emitting device and method for providing phototherapy to the brain
US7651493B2 (en) 2006-03-03 2010-01-26 Covidien Ag System and method for controlling electrosurgical snares
US7648499B2 (en) 2006-03-21 2010-01-19 Covidien Ag System and method for generating radio frequency energy
US7651492B2 (en) 2006-04-24 2010-01-26 Covidien Ag Arc based adaptive control system for an electrosurgical unit
US8753334B2 (en) 2006-05-10 2014-06-17 Covidien Ag System and method for reducing leakage current in an electrosurgical generator
US7668598B2 (en) 2006-05-18 2010-02-23 Uroplasty, Inc. Method and apparatus for stimulating a nerve of a patient
ES2361583T3 (en) 2006-06-28 2011-06-20 Ardian, Inc. Renal neuromodulation system for thermally induced.
US8034049B2 (en) 2006-08-08 2011-10-11 Covidien Ag System and method for measuring initial tissue impedance
US7731717B2 (en) 2006-08-08 2010-06-08 Covidien Ag System and method for controlling RF output during tissue sealing
US8308784B2 (en) 2006-08-24 2012-11-13 Jackson Streeter Low level light therapy for enhancement of neurologic function of a patient affected by Parkinson's disease
US7927329B2 (en) * 2006-09-28 2011-04-19 Covidien Ag Temperature sensing return electrode pad
US7794457B2 (en) 2006-09-28 2010-09-14 Covidien Ag Transformer for RF voltage sensing
US8660635B2 (en) 2006-09-29 2014-02-25 Medtronic, Inc. Method and apparatus for optimizing a computer assisted surgical procedure
EP2091594A4 (en) 2006-12-06 2010-07-07 Spinal Modulation Inc Delivery devices, systems and methods for stimulating nerve tissue on multiple spinal levels
US9314618B2 (en) 2006-12-06 2016-04-19 Spinal Modulation, Inc. Implantable flexible circuit leads and methods of use
CA2671250A1 (en) 2006-12-06 2008-06-12 Spinal Modulation, Inc. Hard tissue anchors and delivery devices
US9427570B2 (en) 2006-12-06 2016-08-30 St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”) Expandable stimulation leads and methods of use
US9044592B2 (en) 2007-01-29 2015-06-02 Spinal Modulation, Inc. Sutureless lead retention features
US8080007B2 (en) 2007-05-07 2011-12-20 Tyco Healthcare Group Lp Capacitive electrosurgical return pad with contact quality monitoring
US8777941B2 (en) 2007-05-10 2014-07-15 Covidien Lp Adjustable impedance electrosurgical electrodes
US7834484B2 (en) 2007-07-16 2010-11-16 Tyco Healthcare Group Lp Connection cable and method for activating a voltage-controlled generator
US8489206B2 (en) 2007-07-16 2013-07-16 Francisco José Arriaza Muñoz Device for neuronal therapies
US8100898B2 (en) 2007-08-01 2012-01-24 Tyco Healthcare Group Lp System and method for return electrode monitoring
US8216220B2 (en) 2007-09-07 2012-07-10 Tyco Healthcare Group Lp System and method for transmission of combined data stream
US8512332B2 (en) 2007-09-21 2013-08-20 Covidien Lp Real-time arc control in electrosurgical generators
US8905920B2 (en) 2007-09-27 2014-12-09 Covidien Lp Bronchoscope adapter and method
US9008793B1 (en) 2007-10-15 2015-04-14 Chenes Llc Multiple electrode radiofrequency generator
US20090204173A1 (en) 2007-11-05 2009-08-13 Zi-Ping Fang Multi-Frequency Neural Treatments and Associated Systems and Methods
US9575140B2 (en) 2008-04-03 2017-02-21 Covidien Lp Magnetic interference detection system and method
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US7890182B2 (en) 2008-05-15 2011-02-15 Boston Scientific Neuromodulation Corporation Current steering for an implantable stimulator device involving fractionalized stimulation pulses
US20090287140A1 (en) * 2008-05-16 2009-11-19 Rittman Iii William J Electrical stimulation and infusion introducer assembly
WO2009147671A1 (en) 2008-06-03 2009-12-10 Superdimension Ltd. Feature-based registration method
US8218847B2 (en) 2008-06-06 2012-07-10 Superdimension, Ltd. Hybrid registration method
US8226639B2 (en) 2008-06-10 2012-07-24 Tyco Healthcare Group Lp System and method for output control of electrosurgical generator
US20090326602A1 (en) 2008-06-27 2009-12-31 Arkady Glukhovsky Treatment of indications using electrical stimulation
US8932207B2 (en) 2008-07-10 2015-01-13 Covidien Lp Integrated multi-functional endoscopic tool
US8403924B2 (en) * 2008-09-03 2013-03-26 Vivant Medical, Inc. Shielding for an isolation apparatus used in a microwave generator
US7848035B2 (en) 2008-09-18 2010-12-07 Photothera, Inc. Single-use lens assembly
JP5688022B2 (en) 2008-09-26 2015-03-25 リリーバント メドシステムズ、インコーポレイテッド Systems and methods for inducing instrument through the interior of the bone
US8180433B2 (en) * 2008-09-30 2012-05-15 Vivant Medical, Inc. Microwave system calibration apparatus, system and method of use
US20100082083A1 (en) * 2008-09-30 2010-04-01 Brannan Joseph D Microwave system tuner
US8287527B2 (en) * 2008-09-30 2012-10-16 Vivant Medical, Inc. Microwave system calibration apparatus and method of use
US8346370B2 (en) * 2008-09-30 2013-01-01 Vivant Medical, Inc. Delivered energy generator for microwave ablation
US8242782B2 (en) 2008-09-30 2012-08-14 Vivant Medical, Inc. Microwave ablation generator control system
US8248075B2 (en) * 2008-09-30 2012-08-21 Vivant Medical, Inc. System, apparatus and method for dissipating standing wave in a microwave delivery system
US8174267B2 (en) * 2008-09-30 2012-05-08 Vivant Medical, Inc. Intermittent microwave energy delivery system
CN102202729B (en) 2008-10-27 2014-11-05 脊髓调制公司 Selective stimulation systems and signal parameters for medical conditions
US20110227694A1 (en) 2008-11-24 2011-09-22 Koninklijke Philips Electronics N.V. Catheter interfacing
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US8808345B2 (en) 2008-12-31 2014-08-19 Medtronic Ardian Luxembourg S.A.R.L. Handle assemblies for intravascular treatment devices and associated systems and methods
US8652129B2 (en) 2008-12-31 2014-02-18 Medtronic Ardian Luxembourg S.A.R.L. Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation
US8262652B2 (en) 2009-01-12 2012-09-11 Tyco Healthcare Group Lp Imaginary impedance process monitoring and intelligent shut-off
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US8255057B2 (en) 2009-01-29 2012-08-28 Nevro Corporation Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US8672934B2 (en) * 2009-03-17 2014-03-18 Stryker Corporation Method for adjusting source impedance and maximizing output by RF generator
WO2010111358A3 (en) 2009-03-24 2011-01-13 Spinal Modulation, Inc. Pain management with stimulation subthreshold to parasthesia
US8611984B2 (en) 2009-04-08 2013-12-17 Covidien Lp Locatable catheter
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
EP3228350A1 (en) 2009-04-22 2017-10-11 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
JP5711221B2 (en) 2009-05-15 2015-04-30 スパイナル・モデュレーション・インコーポレイテッドSpinal Modulation Inc. How to neuromodulation spinal tissue, system, and device
US8498710B2 (en) 2009-07-28 2013-07-30 Nevro Corporation Linked area parameter adjustment for spinal cord stimulation and associated systems and methods
US20110130804A1 (en) * 2009-11-30 2011-06-02 UniMed Investment Inc. Implantable pulsed-radiofrequency micro-stimulation system
US20110208173A1 (en) * 2010-02-24 2011-08-25 Medtronic Vascular, Inc. Methods for Treating sleep apnea via renal Denervation
US8556891B2 (en) 2010-03-03 2013-10-15 Medtronic Ablation Frontiers Llc Variable-output radiofrequency ablation power supply
US8870863B2 (en) 2010-04-26 2014-10-28 Medtronic Ardian Luxembourg S.A.R.L. Catheter apparatuses, systems, and methods for renal neuromodulation
US9084610B2 (en) 2010-10-21 2015-07-21 Medtronic Ardian Luxembourg S.A.R.L. Catheter apparatuses, systems, and methods for renal neuromodulation
WO2012061161A1 (en) 2010-10-25 2012-05-10 Medtronic Ardian Luxembourg S.A.R.L. Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems and methods
CN103313671B (en) 2010-10-25 2017-06-06 美敦力Af卢森堡有限责任公司 And a feedback means for estimating neuromodulation therapy system and method
US9060754B2 (en) 2010-10-26 2015-06-23 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation cryotherapeutic devices and associated systems and methods
US20120143294A1 (en) 2010-10-26 2012-06-07 Medtronic Adrian Luxembourg S.a.r.l. Neuromodulation cryotherapeutic devices and associated systems and methods
WO2012075198A2 (en) 2010-11-30 2012-06-07 Nevro Corporation Extended pain relief via high frequency spinal cord modulation, and associated systems and methods
US9345537B2 (en) 2010-12-30 2016-05-24 Avent, Inc. Electrosurgical tissue treatment method
CA2823592A1 (en) 2011-01-03 2012-07-12 The Regents Of The University Of California High density epidural stimulation for facilitation of locomotion, posture, voluntary movement, and recovery of autonomic, sexual, vasomotor, and cognitive function after neurological injury
JP2014508581A (en) 2011-01-21 2014-04-10 カリフォルニア インスティテュート オブ テクノロジー Parylene-based microelectrode array implants for spinal cord stimulation
CN103561811A (en) 2011-02-02 2014-02-05 脊髓调制公司 Devices, systems and methods for the targeted treatment of movement disorders
CN107361741A (en) 2011-03-24 2017-11-21 加利福尼亚理工学院 Neurostimulator
EP2694150A1 (en) 2011-04-08 2014-02-12 Covidien LP Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery
US20130261420A1 (en) * 2011-06-06 2013-10-03 Semen Kucherov System and method for non-invasive diagnostic of mammals
WO2013036880A1 (en) 2011-09-08 2013-03-14 Thacker James R Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
EP2775899B1 (en) 2011-11-07 2017-08-23 Medtronic Ardian Luxembourg S.à.r.l. Endovascular nerve monitoring devices and associated systems
US9486243B2 (en) * 2011-11-08 2016-11-08 Covidien Lp Systems and methods for treatment of premenstrual dysphoric disorders
EP2776119A4 (en) 2011-11-11 2015-06-03 Univ California Transcutaneous spinal cord stimulation: noninvasive tool for activation of locomotor circuitry
KR20140098780A (en) 2011-11-11 2014-08-08 뉴로이네이블링 테크놀로지스, 인크. Non invasive neuromodulation device for enabling recovery of motor, sensory, autonomic, sexual, vasomotor and cognitive function
US9192766B2 (en) 2011-12-02 2015-11-24 Medtronic Ardian Luxembourg S.A.R.L. Renal neuromodulation methods and devices for treatment of polycystic kidney disease
US9883909B2 (en) 2012-03-08 2018-02-06 Medtronic Ardian Luxembourg S.A.R.L. Renal neuromodulation methods and systems for treatment of hyperaldosteronism
US9750568B2 (en) 2012-03-08 2017-09-05 Medtronic Ardian Luxembourg S.A.R.L. Ovarian neuromodulation and associated systems and methods
EP2822496B1 (en) 2012-03-08 2017-12-20 Medtronic Ardian Luxembourg S.à.r.l. Biomarker sampling in the context of neuromodulation devices and associated systems
WO2013162721A1 (en) 2012-04-27 2013-10-31 Medtronic Ardian Luxembourg Sarl Methods and devices for localized inhibition of inflammation by ablation
US9241752B2 (en) 2012-04-27 2016-01-26 Medtronic Ardian Luxembourg S.A.R.L. Shafts with pressure relief in cryotherapeutic catheters and associated devices, systems, and methods
WO2013162722A1 (en) 2012-04-27 2013-10-31 Medtronic Ardian Luxembourg Sarl Methods and devices for localized disease treatment by ablation
CN107374723A (en) 2012-05-11 2017-11-24 美敦力Af卢森堡有限责任公司 Catheter
CA2996981A1 (en) * 2015-10-26 2017-05-04 Ojai Retinal Technology, Llc Method for heat treating biological tissues using pulsed energy sources
GB201209771D0 (en) 2012-06-01 2012-07-18 Bioinduction Ltd Precision delivery of electrical therapy
US9833614B1 (en) 2012-06-22 2017-12-05 Nevro Corp. Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods
US8951296B2 (en) 2012-06-29 2015-02-10 Medtronic Ardian Luxembourg S.A.R.L. Devices and methods for photodynamically modulating neural function in a human
EP2703042A1 (en) * 2012-08-27 2014-03-05 XAX Kft. RF hyperthermia device for personalized treatment and diagnosis
US8612022B1 (en) 2012-09-13 2013-12-17 Invatec S.P.A. Neuromodulation catheters and associated systems and methods
US20140110296A1 (en) 2012-10-19 2014-04-24 Medtronic Ardian Luxembourg S.A.R.L. Packaging for Catheter Treatment Devices and Associated Devices, Systems, and Methods
CN104968287A (en) 2012-10-22 2015-10-07 美敦力阿迪安卢森堡有限公司 Catheters with enhanced flexibility
US9044575B2 (en) 2012-10-22 2015-06-02 Medtronic Adrian Luxembourg S.a.r.l. Catheters with enhanced flexibility and associated devices, systems, and methods
CA2889478A1 (en) 2012-11-05 2014-05-08 Relievant Medsystems, Inc. Systems and methods for creating curved paths through bone and modulating nerves within the bone
US9095321B2 (en) 2012-11-21 2015-08-04 Medtronic Ardian Luxembourg S.A.R.L. Cryotherapeutic devices having integral multi-helical balloons and methods of making the same
US9017317B2 (en) 2012-12-06 2015-04-28 Medtronic Ardian Luxembourg S.A.R.L. Refrigerant supply system for cryotherapy including refrigerant recompression and associated devices, systems, and methods
US9066726B2 (en) 2013-03-15 2015-06-30 Medtronic Ardian Luxembourg S.A.R.L. Multi-electrode apposition judgment using pressure elements
US9179974B2 (en) 2013-03-15 2015-11-10 Medtronic Ardian Luxembourg S.A.R.L. Helical push wire electrode
US9895539B1 (en) 2013-06-10 2018-02-20 Nevro Corp. Methods and systems for disease treatment using electrical stimulation
US9872719B2 (en) 2013-07-24 2018-01-23 Covidien Lp Systems and methods for generating electrosurgical energy using a multistage power converter
US9636165B2 (en) 2013-07-29 2017-05-02 Covidien Lp Systems and methods for measuring tissue impedance through an electrosurgical cable
US9724151B2 (en) 2013-08-08 2017-08-08 Relievant Medsystems, Inc. Modulating nerves within bone using bone fasteners
US9339332B2 (en) 2013-08-30 2016-05-17 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation catheters with nerve monitoring features for transmitting digital neural signals and associated systems and methods
US9326816B2 (en) 2013-08-30 2016-05-03 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation systems having nerve monitoring assemblies and associated devices, systems, and methods
US9138578B2 (en) 2013-09-10 2015-09-22 Medtronic Ardian Luxembourg S.A.R.L. Endovascular catheters with tuned control members and associated systems and methods
ES2662931T3 (en) 2013-12-09 2018-04-10 Chenes Llc Cooled RF electrode
US20150265459A1 (en) * 2014-02-21 2015-09-24 Circuit Therapeutics, Inc. System and method for therapeutic management of unproductive cough
US9579149B2 (en) 2014-03-13 2017-02-28 Medtronic Ardian Luxembourg S.A.R.L. Low profile catheter assemblies and associated systems and methods
US9409020B2 (en) 2014-05-20 2016-08-09 Nevro Corporation Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods
EP3191178A2 (en) * 2014-09-11 2017-07-19 Ridder, Dirk, De System and method for nested neurostimulation
GB201506851D0 (en) * 2014-09-12 2015-06-03 Innovarius Ltd Apparatus and method for providing hyperthermia therapy
US9113912B1 (en) 2015-01-21 2015-08-25 Serene Medical, Inc. Systems and devices to identify and limit nerve conduction
US9119628B1 (en) 2015-01-21 2015-09-01 Serene Medical, Inc. Systems and devices to identify and limit nerve conduction
US9724521B2 (en) 2015-04-09 2017-08-08 Medtronic, Inc. Frequency based therapy generation
WO2018058057A1 (en) * 2016-09-23 2018-03-29 Falowski Steven M Method and apparatus for intraoperative monitoring of lead placement in dorsal root ganglion stimulation

Citations (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US919139A (en) 1907-12-19 1909-04-20 Joseph S Duke Bin-measuring apparatus.
US3127895A (en) 1962-07-02 1964-04-07 Dynapower System Corp Therapeutic pulse generation and control circuit
US3791373A (en) 1972-03-02 1974-02-12 Univ Southern Illinois Portable electroanesthesia device with automatic power control
US3817254A (en) 1972-05-08 1974-06-18 Medtronic Inc Transcutaneous stimulator and stimulation method
US3888261A (en) 1973-12-07 1975-06-10 Medtronic Inc Time shared stimulator
US3894532A (en) 1974-01-17 1975-07-15 Acupulse Inc Instruments for transcutaneous and subcutaneous investigation and treatment
US3897789A (en) 1973-09-13 1975-08-05 Stanley J Blanchard Acupuncture apparatus
US3911930A (en) 1974-03-01 1975-10-14 Stimulation Tech Method and structure of preventing and treating ileus, and reducing acute pain by electrical pulse stimulation
US3946745A (en) 1973-03-22 1976-03-30 Biopulse Company Limited Apparatus for generating positive and negative electric pulses for application to a living body for therapeutic purposes
US4014347A (en) 1975-05-27 1977-03-29 Staodynamics, Inc. Transcutaneous nerve stimulator device and method
US4055190A (en) 1974-12-19 1977-10-25 Michio Tany Electrical therapeutic apparatus
US4177819A (en) 1978-03-30 1979-12-11 Kofsky Harvey I Muscle stimulating apparatus
US4210151A (en) 1978-09-26 1980-07-01 Stimtech, Inc. Electronic pain control with scanned output parameters
US4237899A (en) 1978-09-26 1980-12-09 Stimtech, Inc. Electronic tissue stimulator with output signal controls
US4324253A (en) 1977-01-28 1982-04-13 Greene Ronald W Transcutaneous pain control and/or muscle stimulating apparatus
US4338945A (en) 1978-03-03 1982-07-13 Clinical Engineering Laboratory Limited Method and randomized electrical stimulation system for pain relief
US4340630A (en) 1980-04-04 1982-07-20 Doty Francis D Low conductivity gas sealed building insulation
DE3151180A1 (en) 1981-01-28 1982-08-19 Ceske Vysoke Uceni Tech Haemodialysestimulator
US4431002A (en) 1981-06-08 1984-02-14 Empi Inc. Modulated deep afferent stimulator
US4442839A (en) 1981-04-27 1984-04-17 Empi, Inc. Method of modulating energy in train of electrical pulses
US4453548A (en) 1981-06-08 1984-06-12 Empi, Inc. Method of improving sensory tolerance with modulated nerve stimulator
WO1985001212A1 (en) 1983-09-19 1985-03-28 Leveen Harry H Catheter with separable balloons
US4520825A (en) 1982-04-30 1985-06-04 Medtronic, Inc. Digital circuit for control of gradual turn-on of electrical tissue stimulators
US4535777A (en) 1981-08-20 1985-08-20 Physio Technology, Inc. Method of providing electrical stimulation of tissue
US4541432A (en) 1982-12-08 1985-09-17 Neurotronic Ltee Electric nerve stimulator device
US4556064A (en) 1983-01-25 1985-12-03 Bruce Pomeranz Electrotherapy acupuncture apparatus and method
US4565200A (en) 1980-09-24 1986-01-21 Cosman Eric R Universal lesion and recording electrode system
US4640286A (en) 1984-11-02 1987-02-03 Staodynamics, Inc. Optimized nerve fiber stimulation
US4671286A (en) 1983-03-04 1987-06-09 Compagnie Francaise d'Electronique Medicale International SA (C.O.F.R.E.M. International SA) RF therapy apparatus
US4723552A (en) 1984-06-04 1988-02-09 James Heaney Transcutaneous electrical nerve stimulation device
US4735204A (en) 1984-09-17 1988-04-05 Cordis Corporation System for controlling an implanted neural stimulator
US4759368A (en) 1986-12-02 1988-07-26 Medical Designs, Inc. Transcutaneous nerve stimulator
US4793353A (en) 1981-06-30 1988-12-27 Borkan William N Non-invasive multiprogrammable tissue stimulator and method
US4887603A (en) 1985-07-22 1989-12-19 Empi, Inc. Medical stimulator with stimulation signal characteristics modulated as a function of stimulation signal frequency
US4907589A (en) * 1988-04-29 1990-03-13 Cosman Eric R Automatic over-temperature control apparatus for a therapeutic heating device
US4917092A (en) 1988-07-13 1990-04-17 Medical Designs, Inc. Transcutaneous nerve stimulator for treatment of sympathetic nerve dysfunction
US4922908A (en) 1985-07-22 1990-05-08 Empi, Inc. Medical stimulator with stimulation signal characteristics modulated as a function of stimulation signal frequency
US4929865A (en) 1987-01-29 1990-05-29 Visual Ease, Inc. Eye comfort panel
US4938223A (en) 1988-03-28 1990-07-03 T. H. Charters, Inc. Transcutaneous nerve block device
USRE33420E (en) 1984-09-17 1990-11-06 Cordis Corporation System for controlling an implanted neural stimulator
US4977895A (en) 1989-05-22 1990-12-18 Ely Shavit Pasternak Electrical apparatus for medical treatment
US4989605A (en) 1989-03-31 1991-02-05 Joel Rossen Transcutaneous electrical nerve stimulation (TENS) device
US5036850A (en) 1989-08-25 1991-08-06 Staodyn, Inc. Biphasic pulse output stage for electronic stimulating device
US5052391A (en) 1990-10-22 1991-10-01 R.F.P., Inc. High frequency high intensity transcutaneous electrical nerve stimulator and method of treatment
US5058605A (en) 1989-02-22 1991-10-22 Ceske Vysoke Uceni Technicke Method and device for the controlled local, non-invasive application of dc pulses to human and animal tissues
US5063929A (en) 1989-08-25 1991-11-12 Staodyn, Inc. Electronic stimulating device having timed treatment of varying intensity and method therefor
US5109847A (en) 1991-05-21 1992-05-05 E.P. Inc. Non-intrusive analgesic neuroaugmentive apparatus and management system
US5117826A (en) 1987-02-02 1992-06-02 Staodyn, Inc. Combined nerve fiber and body tissue stimulation apparatus and method
US5233515A (en) 1990-06-08 1993-08-03 Cosman Eric R Real-time graphic display of heat lesioning parameters in a clinical lesion generator system
WO1994000188A1 (en) 1992-06-24 1994-01-06 Cyberonics, Inc. Treatment of neuropsychiatric disorders by nerve stimulation
US5330515A (en) 1992-06-17 1994-07-19 Cyberonics, Inc. Treatment of pain by vagal afferent stimulation
US5342409A (en) 1990-03-07 1994-08-30 Medtronic, Inc. Position-responsive neuro stimulator
US5350414A (en) 1991-12-10 1994-09-27 Electro Science Technologies, Inc. Local application microprocessor based nerve and muscle stimulator
US5370672A (en) 1992-10-30 1994-12-06 The Johns Hopkins University Computer-controlled neurological stimulation system
US5417719A (en) 1993-08-25 1995-05-23 Medtronic, Inc. Method of using a spinal cord stimulation lead
US5433739A (en) * 1993-11-02 1995-07-18 Sluijter; Menno E. Method and apparatus for heating an intervertebral disc for relief of back pain
US5478303A (en) 1992-09-18 1995-12-26 Foley-Nolan; Darragh Electromagnetic apparatus for use in therapy
US5562717A (en) 1992-05-23 1996-10-08 Axelgaard Manufacturing Company, Ltd. Electrical stimulation for treatment of incontinence and other neuromuscular disorders
US5569242A (en) 1994-05-06 1996-10-29 Lax; Ronald G. Method and apparatus for controlled contraction of soft tissue
US5571147A (en) 1993-11-02 1996-11-05 Sluijter; Menno E. Thermal denervation of an intervertebral disc for relief of back pain
US5573552A (en) 1992-09-05 1996-11-12 Hansjurgens; Achim Electrotherapeutic apparatus
US5584863A (en) * 1993-06-24 1996-12-17 Electropharmacology, Inc. Pulsed radio frequency electrotherapeutic system
WO1997004953A1 (en) 1995-08-02 1997-02-13 Pkl Verpackungssysteme Gmbh Method and device for bonding pourers to flat-topped parallelepidal cartons filled with free-flowing products
WO1997013550A1 (en) 1995-10-13 1997-04-17 Jacob Zabara Heart rhythm stabilization using a neurocybernetic prosthesis
US5643330A (en) 1994-01-24 1997-07-01 Medtronic, Inc. Multichannel apparatus for epidural spinal cord stimulation
US5658322A (en) 1995-10-11 1997-08-19 Regeneration Technology Bio-active frequency generator and method
US5690692A (en) 1995-10-11 1997-11-25 Regeneration Technology Bio-active frequency generator and method
EP0811395A2 (en) 1996-06-07 1997-12-10 Quest Medical, Inc. Multiprogrammable tissue stimulator
US5702429A (en) 1996-04-04 1997-12-30 Medtronic, Inc. Neural stimulation techniques with feedback
WO1998004888A1 (en) 1996-07-29 1998-02-05 Kansei Corporation Measured value indicator system
US5759158A (en) * 1995-07-28 1998-06-02 E.P. Technologies, Inc. Systems and methods for conducting electrophysiological testing using high-voltage energy pulses to stun heart tissue
US5800481A (en) 1995-12-28 1998-09-01 Loos; Hendricus G. Thermal excitation of sensory resonances
US5817139A (en) 1997-05-22 1998-10-06 Polytronics, Ltd. Skin-contact type antiallergic skin-therapeutic apparatus using voltage pulse train
USRE35987E (en) 1990-06-05 1998-12-08 Staodyn, Inc. Output pulse compensation for therapeutic-type electronic devices
US5908444A (en) 1997-06-19 1999-06-01 Healing Machines, Inc. Complex frequency pulsed electromagnetic generator and method of use
US5925070A (en) 1996-04-04 1999-07-20 Medtronic, Inc. Techniques for adjusting the locus of excitation of electrically excitable tissue
US5948007A (en) 1997-04-30 1999-09-07 Medtronic, Inc. Dual channel implantation neurostimulation techniques
US5951546A (en) 1994-12-13 1999-09-14 Lorentzen; Torben Electrosurgical instrument for tissue ablation, an apparatus, and a method for providing a lesion in damaged and diseased tissue from a mammal
US5983141A (en) 1996-06-27 1999-11-09 Radionics, Inc. Method and apparatus for altering neural tissue function
US6035236A (en) 1998-07-13 2000-03-07 Bionergy Therapeutics, Inc. Methods and apparatus for electrical microcurrent stimulation therapy
US6161044A (en) 1998-11-23 2000-12-12 Synaptic Corporation Method and apparatus for treating chronic pain syndromes, tremor, dementia and related disorders and for inducing electroanesthesia using high frequency, high intensity transcutaneous electrical nerve stimulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0156854B1 (en) * 1983-09-14 1990-09-05 ZABARA, Jacob Neurocybernetic prosthesis

Patent Citations (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US919139A (en) 1907-12-19 1909-04-20 Joseph S Duke Bin-measuring apparatus.
US3127895A (en) 1962-07-02 1964-04-07 Dynapower System Corp Therapeutic pulse generation and control circuit
US3791373A (en) 1972-03-02 1974-02-12 Univ Southern Illinois Portable electroanesthesia device with automatic power control
US3817254A (en) 1972-05-08 1974-06-18 Medtronic Inc Transcutaneous stimulator and stimulation method
US3946745A (en) 1973-03-22 1976-03-30 Biopulse Company Limited Apparatus for generating positive and negative electric pulses for application to a living body for therapeutic purposes
US3897789A (en) 1973-09-13 1975-08-05 Stanley J Blanchard Acupuncture apparatus
US3888261A (en) 1973-12-07 1975-06-10 Medtronic Inc Time shared stimulator
US3894532A (en) 1974-01-17 1975-07-15 Acupulse Inc Instruments for transcutaneous and subcutaneous investigation and treatment
US3911930A (en) 1974-03-01 1975-10-14 Stimulation Tech Method and structure of preventing and treating ileus, and reducing acute pain by electrical pulse stimulation
US4055190A (en) 1974-12-19 1977-10-25 Michio Tany Electrical therapeutic apparatus
US4014347A (en) 1975-05-27 1977-03-29 Staodynamics, Inc. Transcutaneous nerve stimulator device and method
US4324253A (en) 1977-01-28 1982-04-13 Greene Ronald W Transcutaneous pain control and/or muscle stimulating apparatus
US4338945A (en) 1978-03-03 1982-07-13 Clinical Engineering Laboratory Limited Method and randomized electrical stimulation system for pain relief
US4177819A (en) 1978-03-30 1979-12-11 Kofsky Harvey I Muscle stimulating apparatus
US4237899A (en) 1978-09-26 1980-12-09 Stimtech, Inc. Electronic tissue stimulator with output signal controls
US4210151A (en) 1978-09-26 1980-07-01 Stimtech, Inc. Electronic pain control with scanned output parameters
US4340630A (en) 1980-04-04 1982-07-20 Doty Francis D Low conductivity gas sealed building insulation
US4565200A (en) 1980-09-24 1986-01-21 Cosman Eric R Universal lesion and recording electrode system
US4790319A (en) 1981-01-28 1988-12-13 Ceske Vysoke Uceni Technicke V Praze Stimulator for hemodialysis
DE3151180A1 (en) 1981-01-28 1982-08-19 Ceske Vysoke Uceni Tech Haemodialysestimulator
US4442839A (en) 1981-04-27 1984-04-17 Empi, Inc. Method of modulating energy in train of electrical pulses
US4431002A (en) 1981-06-08 1984-02-14 Empi Inc. Modulated deep afferent stimulator
US4453548A (en) 1981-06-08 1984-06-12 Empi, Inc. Method of improving sensory tolerance with modulated nerve stimulator
US4793353A (en) 1981-06-30 1988-12-27 Borkan William N Non-invasive multiprogrammable tissue stimulator and method
US4535777A (en) 1981-08-20 1985-08-20 Physio Technology, Inc. Method of providing electrical stimulation of tissue
US4520825A (en) 1982-04-30 1985-06-04 Medtronic, Inc. Digital circuit for control of gradual turn-on of electrical tissue stimulators
US4541432A (en) 1982-12-08 1985-09-17 Neurotronic Ltee Electric nerve stimulator device
US4556064A (en) 1983-01-25 1985-12-03 Bruce Pomeranz Electrotherapy acupuncture apparatus and method
US4671286A (en) 1983-03-04 1987-06-09 Compagnie Francaise d'Electronique Medicale International SA (C.O.F.R.E.M. International SA) RF therapy apparatus
WO1985001212A1 (en) 1983-09-19 1985-03-28 Leveen Harry H Catheter with separable balloons
US4723552A (en) 1984-06-04 1988-02-09 James Heaney Transcutaneous electrical nerve stimulation device
US4735204A (en) 1984-09-17 1988-04-05 Cordis Corporation System for controlling an implanted neural stimulator
USRE33420E (en) 1984-09-17 1990-11-06 Cordis Corporation System for controlling an implanted neural stimulator
US4640286A (en) 1984-11-02 1987-02-03 Staodynamics, Inc. Optimized nerve fiber stimulation
US4887603A (en) 1985-07-22 1989-12-19 Empi, Inc. Medical stimulator with stimulation signal characteristics modulated as a function of stimulation signal frequency
US4922908A (en) 1985-07-22 1990-05-08 Empi, Inc. Medical stimulator with stimulation signal characteristics modulated as a function of stimulation signal frequency
US4759368A (en) 1986-12-02 1988-07-26 Medical Designs, Inc. Transcutaneous nerve stimulator
US4929865A (en) 1987-01-29 1990-05-29 Visual Ease, Inc. Eye comfort panel
US5117826A (en) 1987-02-02 1992-06-02 Staodyn, Inc. Combined nerve fiber and body tissue stimulation apparatus and method
US4938223A (en) 1988-03-28 1990-07-03 T. H. Charters, Inc. Transcutaneous nerve block device
US4907589A (en) * 1988-04-29 1990-03-13 Cosman Eric R Automatic over-temperature control apparatus for a therapeutic heating device
US4917092A (en) 1988-07-13 1990-04-17 Medical Designs, Inc. Transcutaneous nerve stimulator for treatment of sympathetic nerve dysfunction
US5058605A (en) 1989-02-22 1991-10-22 Ceske Vysoke Uceni Technicke Method and device for the controlled local, non-invasive application of dc pulses to human and animal tissues
US4989605A (en) 1989-03-31 1991-02-05 Joel Rossen Transcutaneous electrical nerve stimulation (TENS) device
US4977895A (en) 1989-05-22 1990-12-18 Ely Shavit Pasternak Electrical apparatus for medical treatment
US5063929A (en) 1989-08-25 1991-11-12 Staodyn, Inc. Electronic stimulating device having timed treatment of varying intensity and method therefor
US5036850A (en) 1989-08-25 1991-08-06 Staodyn, Inc. Biphasic pulse output stage for electronic stimulating device
US5342409A (en) 1990-03-07 1994-08-30 Medtronic, Inc. Position-responsive neuro stimulator
USRE35987E (en) 1990-06-05 1998-12-08 Staodyn, Inc. Output pulse compensation for therapeutic-type electronic devices
US5233515A (en) 1990-06-08 1993-08-03 Cosman Eric R Real-time graphic display of heat lesioning parameters in a clinical lesion generator system
US5052391A (en) 1990-10-22 1991-10-01 R.F.P., Inc. High frequency high intensity transcutaneous electrical nerve stimulator and method of treatment
US5109847A (en) 1991-05-21 1992-05-05 E.P. Inc. Non-intrusive analgesic neuroaugmentive apparatus and management system
US5350414A (en) 1991-12-10 1994-09-27 Electro Science Technologies, Inc. Local application microprocessor based nerve and muscle stimulator
US5562717A (en) 1992-05-23 1996-10-08 Axelgaard Manufacturing Company, Ltd. Electrical stimulation for treatment of incontinence and other neuromuscular disorders
US5702428A (en) 1992-05-23 1997-12-30 Axelgaard Manufacturing Company, Ltd. Electrical stimulation for treatment of incontinence and other neuro-muscular disorders
US5330515A (en) 1992-06-17 1994-07-19 Cyberonics, Inc. Treatment of pain by vagal afferent stimulation
WO1994000188A1 (en) 1992-06-24 1994-01-06 Cyberonics, Inc. Treatment of neuropsychiatric disorders by nerve stimulation
US5573552A (en) 1992-09-05 1996-11-12 Hansjurgens; Achim Electrotherapeutic apparatus
US5478303A (en) 1992-09-18 1995-12-26 Foley-Nolan; Darragh Electromagnetic apparatus for use in therapy
US5370672A (en) 1992-10-30 1994-12-06 The Johns Hopkins University Computer-controlled neurological stimulation system
US5584863A (en) * 1993-06-24 1996-12-17 Electropharmacology, Inc. Pulsed radio frequency electrotherapeutic system
US5417719A (en) 1993-08-25 1995-05-23 Medtronic, Inc. Method of using a spinal cord stimulation lead
US5571147A (en) 1993-11-02 1996-11-05 Sluijter; Menno E. Thermal denervation of an intervertebral disc for relief of back pain
US5433739A (en) * 1993-11-02 1995-07-18 Sluijter; Menno E. Method and apparatus for heating an intervertebral disc for relief of back pain
US5643330A (en) 1994-01-24 1997-07-01 Medtronic, Inc. Multichannel apparatus for epidural spinal cord stimulation
US5569242A (en) 1994-05-06 1996-10-29 Lax; Ronald G. Method and apparatus for controlled contraction of soft tissue
US5951546A (en) 1994-12-13 1999-09-14 Lorentzen; Torben Electrosurgical instrument for tissue ablation, an apparatus, and a method for providing a lesion in damaged and diseased tissue from a mammal
US5759158A (en) * 1995-07-28 1998-06-02 E.P. Technologies, Inc. Systems and methods for conducting electrophysiological testing using high-voltage energy pulses to stun heart tissue
WO1997004953A1 (en) 1995-08-02 1997-02-13 Pkl Verpackungssysteme Gmbh Method and device for bonding pourers to flat-topped parallelepidal cartons filled with free-flowing products
US5690692A (en) 1995-10-11 1997-11-25 Regeneration Technology Bio-active frequency generator and method
US5658322A (en) 1995-10-11 1997-08-19 Regeneration Technology Bio-active frequency generator and method
WO1997013550A1 (en) 1995-10-13 1997-04-17 Jacob Zabara Heart rhythm stabilization using a neurocybernetic prosthesis
US5800481A (en) 1995-12-28 1998-09-01 Loos; Hendricus G. Thermal excitation of sensory resonances
US5925070A (en) 1996-04-04 1999-07-20 Medtronic, Inc. Techniques for adjusting the locus of excitation of electrically excitable tissue
US5814092A (en) 1996-04-04 1998-09-29 Medtronic Inc. Neural stimulation techniques with feedback
US5913882A (en) 1996-04-04 1999-06-22 Medtronic Inc. Neural stimulation techniques with feedback
US5702429A (en) 1996-04-04 1997-12-30 Medtronic, Inc. Neural stimulation techniques with feedback
EP0811395A2 (en) 1996-06-07 1997-12-10 Quest Medical, Inc. Multiprogrammable tissue stimulator
US5938690A (en) 1996-06-07 1999-08-17 Advanced Neuromodulation Systems, Inc. Pain management system and method
US5983141A (en) 1996-06-27 1999-11-09 Radionics, Inc. Method and apparatus for altering neural tissue function
WO1998004888A1 (en) 1996-07-29 1998-02-05 Kansei Corporation Measured value indicator system
US5948007A (en) 1997-04-30 1999-09-07 Medtronic, Inc. Dual channel implantation neurostimulation techniques
US5817139A (en) 1997-05-22 1998-10-06 Polytronics, Ltd. Skin-contact type antiallergic skin-therapeutic apparatus using voltage pulse train
US5908444A (en) 1997-06-19 1999-06-01 Healing Machines, Inc. Complex frequency pulsed electromagnetic generator and method of use
US6275735B1 (en) 1998-07-13 2001-08-14 Bionergy Therapeutics, Inc. Methods and apparatus for electrical microcurrent stimulation therapy
US6035236A (en) 1998-07-13 2000-03-07 Bionergy Therapeutics, Inc. Methods and apparatus for electrical microcurrent stimulation therapy
US6161044A (en) 1998-11-23 2000-12-12 Synaptic Corporation Method and apparatus for treating chronic pain syndromes, tremor, dementia and related disorders and for inducing electroanesthesia using high frequency, high intensity transcutaneous electrical nerve stimulation

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Cosman & Cosman, "Methods of Making Nervous System Lesions," Neurosurgery, pp. 2490-2499.
Cosman et al., "Theoretical Aspects of Radiofrequency Lesions in the Dorsal Root Entry Zone," Neurosurgery, vol. 15, No. 6, pp. 945-950, 1984.
Guttman et al., "Squid Axion Membrane Response to White Noise Stimulation," Biophysical Journal, vol. 14, pp. 941-955, 1974.
International Search Report: PCT/US 97/11145, Oct. 13, 1997.
Radionics, "RFG-3C Graphics: RF Lesion Generator System with Graphics," 1996.
Salkoff & Kelly, "Atmospheric Electricity and Sun-Weather Relationships," Nature, vol. 273, No. 5658, pp. 3-5, May 11, 1978.
Terman, Frederick Emmons, "Radio Engineering," New York, Mcgraw-Hill Book Company, Inc., 1947.

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110144634A1 (en) * 2005-08-02 2011-06-16 Neurotherm, Inc. Method and Apparatus for Diagnosing and Treating Neural Dysfunction
US8000785B2 (en) 2005-08-02 2011-08-16 Neurotherm, Inc. Method and apparatus for diagnosing and treating neural dysfunction
US8265747B2 (en) 2005-08-02 2012-09-11 Neurotherm, Inc. Method and apparatus for diagnosing and treating neural dysfunction
US8560062B2 (en) 2005-08-02 2013-10-15 Neurotherm, Inc. Method and apparatus for diagnosing and treating neural dysfunction
US8818503B2 (en) 2005-08-02 2014-08-26 Neurotherm, Inc. Method and apparatus for diagnosing and treating neural dysfunction
US20090274471A1 (en) * 2008-04-30 2009-11-05 General Instrument Corporation Method and apparatus for controlling the optical output power from a burst mode laser
US9479255B2 (en) * 2008-04-30 2016-10-25 Arris Enterprises, Inc. Method and apparatus for controlling the optical output power from a burst mode laser

Also Published As

Publication number Publication date Type
EP0959944B1 (en) 2010-12-08 grant
DE69740073D1 (en) 2011-01-20 grant
WO1997049453A1 (en) 1997-12-31 application
US5983141A (en) 1999-11-09 grant
CA2272125A1 (en) 1997-12-31 application
ES2355462T3 (en) 2011-03-28 grant
US6259952B1 (en) 2001-07-10 grant
EP0959944A1 (en) 1999-12-01 application

Similar Documents

Publication Publication Date Title
US3650275A (en) Method and apparatus for controlling anal incontinence
US6853863B2 (en) Electro therapy method and apparatus
US7146210B2 (en) Apparatus and method for optimizing tumor treatment efficiency by electric fields
US6623454B1 (en) System and method for electrosurgical tissue contraction
US7174213B2 (en) Electrical stimulation strategies to reduce the incidence of seizures
US6328735B1 (en) Thermal ablation system
US7937143B2 (en) Methods and apparatus for inducing controlled renal neuromodulation
US6901295B2 (en) Method and apparatus for electrical stimulation of the lower esophageal sphincter
US6529775B2 (en) System and method employing indwelling RF catheter for systemic patient warming by application of dielectric heating
US6730078B2 (en) RF ablation apparatus and method using multi-frequency energy delivery
US7799021B2 (en) Electrosurgical treatment in conjunction with monitoring
US5433739A (en) Method and apparatus for heating an intervertebral disc for relief of back pain
US5222494A (en) Implantable tissue stimulator output stabilization system
US4431002A (en) Modulated deep afferent stimulator
US6014588A (en) Facet joint pain relief method and apparatus
US20080183258A1 (en) Electrode assembly with fibers for a medical device
US5571150A (en) Treatment of patients in coma by nerve stimulation
US20030055457A1 (en) Pulsewidth electrical stimulation
US20090062873A1 (en) Methods and systems for thermally-induced renal neuromodulation
US20070083239A1 (en) Methods and apparatus for inducing, monitoring and controlling renal neuromodulation
US7337004B2 (en) Method and apparatus for veterinary RF pain management
US20050261672A1 (en) Systems and methods for selective denervation of heart dysrhythmias
US20040210270A1 (en) High frequency pulse generator for an implantable neurostimulator
US20080027505A1 (en) System and method for treatment of headaches
US20060149341A1 (en) Electrodes for applying an electric field in-vivo over an extended period of time

Legal Events

Date Code Title Description
REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees